Baxter International Inc. (BAX) to Issue Quarterly Dividend of $0.01 on October 1st

Baxter International Inc. (NYSE:BAX) declared a quarterly dividend on Wednesday, July 29th. Investors of record on Friday, August 28th will be paid a dividend of 0.01 per share by the medical instruments supplier on Thursday, October 1st. This represents a c) dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, August 28th.

Baxter International has decreased its dividend payment by an average of 0.1%per year over the last three years. Baxter International has a dividend payout ratio of 1.5% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Baxter International to earn $2.01 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 2.0%.

Baxter International Stock Performance

NYSE BAX opened at $26.27 on Wednesday. The company has a market cap of $13.58 billion, a P/E ratio of -12.69, a PEG ratio of 4.01 and a beta of 0.60. The company has a fifty day simple moving average of $23.86 and a 200 day simple moving average of $20.45. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 1.39. Baxter International has a 12-month low of $15.73 and a 12-month high of $30.00.

Baxter International (NYSE:BAX) last released its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.19. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. The firm had revenue of $2.96 billion for the quarter, compared to the consensus estimate of $2.80 billion. During the same quarter in the prior year, the company posted $0.59 earnings per share. The business’s revenue was up 5.3% on a year-over-year basis. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. Sell-side analysts predict that Baxter International will post 2.04 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. BlackRock Inc. bought a new position in Baxter International in the 2nd quarter valued at $1,744,874,000. Pzena Investment Management LLC bought a new stake in shares of Baxter International during the 2nd quarter worth $1,392,098,000. California State Teachers Retirement System raised its stake in shares of Baxter International by 2,009.1% during the 2nd quarter. California State Teachers Retirement System now owns 12,720,343 shares of the medical instruments supplier’s stock worth $271,198,000 after purchasing an additional 12,117,222 shares during the period. Equity Investment Corp purchased a new position in shares of Baxter International in the 2nd quarter worth about $146,815,000. Finally, Bank of America Corp DE purchased a new position in shares of Baxter International in the 2nd quarter worth about $132,993,000. Hedge funds and other institutional investors own 90.19% of the company’s stock.

About Baxter International

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.